TY - JOUR
T1 - A Novel peptide prevents death in enriched neuronal cultures
AU - Zemlyak, Ilona
AU - Furman, Sharon
AU - Brenneman, Douglas E.
AU - Gozes, Illana
N1 - Funding Information:
This study was supported by the US–Israel Binational Science Foundation, the Israel Science Foundation and the Institute for the Study of Aging, Inc. Professor Illana Gozes is the incumbent of the Lily and Avraham Gildor Chair for the investigation of growth factors. This work is in partial fulfillment of the requirements toward Ph.D. degrees of Ms. Ilona Zemlyak and Ms. Sharon Furman. We thank Professor Ina Fabian for the glucose deprivation protocol and Professor Mati Fridkin and Ms. Sara Rubinraut for the help with peptide synthesis.
PY - 2000/12/22
Y1 - 2000/12/22
N2 - We have recently cloned a novel protein (activity-dependent neuroprotective protein, ADNP) containing an 8-amino-acid, femtomolar-acting peptide, NAPVSIPQ (NAP). Here we show, for the first time, that NAP exerted a protective effect on glia-depleted neurons in culture. The number of surviving neurons was assessed in cerebral cortical cultures derived from newborn rats. In these cultures, a 24-h treatment with the β-amyloid peptide (the Alzheimer's disease associated toxin) induced a 30-40% reduction in neuronal survival that was prevented by NAP (10-13-10-11 M). Maximal survival was achieved at NAP concentrations of 10-12 M. In a second set of experiments, a 5-day incubation period, with NAP added once (at the beginning of the incubation period) exhibited maximal protection at 10-10 M NAP. In a third set of experiments, a 10-min period of glucose deprivation resulted in a 30-40% neuronal death that was prevented by a 24-h incubation with NAP. Glucose deprivation coupled with β-amyloid treatment did not increase neuronal death, suggesting a common pathway. We thus conclude, that NAP can prevent neurotoxicity associated with direct action of the β-amyloid peptide on neurons, perhaps through protection against impaired glucose metabolism. Copyright (C) 2000 Elsevier Science B.V.
AB - We have recently cloned a novel protein (activity-dependent neuroprotective protein, ADNP) containing an 8-amino-acid, femtomolar-acting peptide, NAPVSIPQ (NAP). Here we show, for the first time, that NAP exerted a protective effect on glia-depleted neurons in culture. The number of surviving neurons was assessed in cerebral cortical cultures derived from newborn rats. In these cultures, a 24-h treatment with the β-amyloid peptide (the Alzheimer's disease associated toxin) induced a 30-40% reduction in neuronal survival that was prevented by NAP (10-13-10-11 M). Maximal survival was achieved at NAP concentrations of 10-12 M. In a second set of experiments, a 5-day incubation period, with NAP added once (at the beginning of the incubation period) exhibited maximal protection at 10-10 M NAP. In a third set of experiments, a 10-min period of glucose deprivation resulted in a 30-40% neuronal death that was prevented by a 24-h incubation with NAP. Glucose deprivation coupled with β-amyloid treatment did not increase neuronal death, suggesting a common pathway. We thus conclude, that NAP can prevent neurotoxicity associated with direct action of the β-amyloid peptide on neurons, perhaps through protection against impaired glucose metabolism. Copyright (C) 2000 Elsevier Science B.V.
KW - Activity-dependent neuroprotective protein
KW - Activity-dependent neurotrophic factor
KW - Cerebral cortical cultures
KW - Vasoactive intestinal peptide
UR - http://www.scopus.com/inward/record.url?scp=0034704449&partnerID=8YFLogxK
U2 - 10.1016/S0167-0115(00)00198-1
DO - 10.1016/S0167-0115(00)00198-1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0034704449
SN - 0167-0115
VL - 96
SP - 39
EP - 43
JO - Regulatory Peptides
JF - Regulatory Peptides
IS - 1-2
ER -